Health Care Costs Survey – Toplines
This document includes the toplines from the joint USA Today/Kaiser/Harvard School of Public Health survey exploring Americans’ views on health care costs. Survey Toplines (.pdf)
Search
-
-
The Use of Oregon’s Evidence-Based Reviews for Medicaid Pharmacy Policies: Experiences in Four States
ReportThis report explores how four state Medicaid programs — Washington, Wyoming, Minnesota, and North Carolina — differ in their use of Oregon’s Drug Effectiveness Review Project (DERP) to manage their prescription drug benefit. Report (.pdf)
-
Women and Health Care: A National Profile
ReportA new national survey of women on their health finds that a substantial percentage of women cannot afford to go to the doctor or get prescriptions filled. Although a majority of women are in good health and satisfied with their health care, many have health problems and do not get adequate levels of preventive care. The report also examines women’s health status, health care costs, insurance, access to care, prevention, and their role in family…
-
Women and Health Care: A National Profile – Report
ReportReport - Women and Health Care: A National Profile Women and Health Care: A National Profile is a nationally representative telephone survey of 2,766 women ages 18 and older. A shorter companion survey of 507 men was also conducted. Full Report (.pdf) Report Highlights (.pdf) Introduction and Methods (.pdf) Chapter 1: The Demographics of Women (.pdf) Chapter 2: The Health of Women (.pdf) Chapter 3: Women and Health Insurance Coverage (.pdf) Chapter 4: Women's Access…
-
March/April 2005 Kaiser Health Poll Report – Toplines
Poll FindingHealth News Index March/April, 2005 The March/April Kaiser Health Poll Report featured topic explores the public's views on the Medicare prescription drug benefit. This featured topic covers the historical perspective from before the law was passed as well as current views and understanding of the benefit, including how seniors are getting information about this plan, whether they think they have enough information and whether or not they plan to enroll. Additionally, the featured topic explores…
-
National ADAP Monitoring Project 2005 Annual Report
ReportThe National ADAP Monitoring Report, 2005 provides the latest data on state AIDS Drug Assistance Programs (ADAPs). ADAPs, authorized under Title II of the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act, provide HIV/AIDS-related prescription drugs to uninsured and underinsured individuals living with HIV/AIDS. ADAPs operate in 57 U.S. states, territories, and associated jurisdictions. The report, the ninth in an annual series, was prepared by the Kaiser Family Foundation and the National Alliance of State…
-
National ADAP Monitoring Project, Annual Report, April 2005
Event Date:EventThe National ADAP Monitoring Report, 2005 provides the latest data on state AIDS Drug Assistance Programs (ADAPs). ADAPs, authorized under Title II of the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act, provide HIV/AIDS-related prescription drugs to uninsured and underinsured individuals living with HIV/AIDS. ADAPs operate in 57 U.S. states, territories, and associated jurisdictions. The report, the ninth in an annual series, was prepared by the Kaiser Family Foundation and the National Alliance of State…
-
Prescription Drug Spending Under The MMA: Modeling The Impact On Out-of-Pocket Costs
Event Date:EventThis report projects the impact of the new Medicare drug benefit on out-of-pocket spending for people who enroll in 2006. The analysis is based on a model developed by the Actuarial Research Corporation for the Kaiser Family Foundation. The model generally conforms to the Congressional Budget Office’s assumptions and projections about Medicare drug benefit spending and participation rates for the new benefit and for the low-income subsidy. The report was released at a briefing in…
-
Policy Workshop on Formularies and Medicare
Event Date:EventThe Kaiser Family Foundation hosted a March 14, 2005 policy workshop on the use of drug formularies in the private sector and their potential implications for beneficiaries under the new Medicare drug benefit, set to go into effect January 1, 2006. The workshop involved an expert panel, including perspectives from a health plan, a pharmacy benefits manager, a physician, the Centers for Medicare & Medicaid Services and policy experts. Agenda (.pdf) Presentation (.pdf) Speaker Biographies…
-
Follow The Pill: Understanding the U.S. Commercial Pharmaceutical Supply Chain
ReportThe report describes the U.S. pharmaceutical supply chain, following prescription drugs as they move from manufacturers, to wholesale distributors, to pharmacies, and ultimately to patients. The report describes both the physical distribution of drugs through the chain, as well as the flow of money and the financial relationships among the key players. It was prepared for the Foundation by Dan Mendelson and The Health Strategies Consultancy. Report (.pdf)